Tarsus Pharmaceuticals Inc. (TARS)
Market Closed
10 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
81. 12
-1.65
-1.9935%
Pre Market
$
+1.88 +2.3176% 83. 00
3.75B Market Cap
- P/E Ratio
- Div Yield
403,271 Volume
-4.18 Eps
$ 82.77
Previous Close 
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tarsus Pharmaceuticals Inc. (TARS) Statistics
Valuation metrics
Market Cap 3.75B
Enterprise value 3.79B
Trailing P/E (ttm) -83.28
Forward P/E -
PEG ratio -1
Price/Sales (ttm) 6.44
Price/Book (mrq) 11.36
Enterprise Value/Revenue 6.25
Enterprise Value/EBITDA -107.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.45M
Average volume (90 days) 826.2K
Price summary
52-Week low 48.2
52-Week high 91.53
Beta -
50-Day moving average 67.89
200-Day moving average 66.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.08%
Operating margin -0.08%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.36
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 3.2%
Book value per share (mrq) 7.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
